Retraction Note: Fibrauretine reduces ischemia/reperfusion injury via RISK/eNOS activation.
Naunyn Schmiedebergs Arch Pharmacol. 2020 Dec 8. doi: 10.1007/s00210-020-02027-5. Online ahead of print.
Naunyn Schmiedebergs Arch Pharmacol. 2020.
PMID: 33289873